FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1951830410> ?p ?o ?g. }

• W1951830410 endingPage "17586" @default.
• W1951830410 startingPage "17576" @default.
• W1951830410 abstract "γ-Glutamyl transpeptidase 1 (GGT1) is a cell surface, N-terminal nucleophile hydrolase that cleaves glutathione and other γ-glutamyl compounds. GGT1 expression is essential in cysteine homeostasis, and its induction has been implicated in the pathology of asthma, reperfusion injury, and cancer. In this study, we report four new crystal structures of human GGT1 (hGGT1) that show conformational changes within the active site as the enzyme progresses from the free enzyme to inhibitor-bound tetrahedral transition states and finally to the glutamate-bound structure prior to the release of this final product of the reaction. The structure of the apoenzyme shows flexibility within the active site. The serine-borate-bound hGGT1 crystal structure demonstrates that serine-borate occupies the active site of the enzyme, resulting in an enzyme-inhibitor complex that replicates the enzyme's tetrahedral intermediate/transition state. The structure of GGsTop-bound hGGT1 reveals its interactions with the enzyme and why neutral phosphonate diesters are more potent inhibitors than monoanionic phosphonates. These structures are the first structures for any eukaryotic GGT that include a molecule in the active site covalently bound to the catalytic Thr-381. The glutamate-bound structure shows the conformation of the enzyme prior to release of the final product and reveals novel information regarding the displacement of the main chain atoms that form the oxyanion hole and movement of the lid loop region when the active site is occupied. These data provide new insights into the mechanism of hGGT1-catalyzed reactions and will be invaluable in the development of new classes of hGGT1 inhibitors for therapeutic use.Background: γ-Glutamyl transpeptidase 1 (GGT1) plays a role in asthma, reperfusion injury, and cancer.Results: We report four new crystal structures of human GGT1, including the free enzyme, inhibitor-bound transition states, and glutamate-bound enzyme.Conclusion: Novel enzyme-substrate interactions and movement of the catalytic nucleophile, oxyanion hole, and lid loop were revealed.Significance: This structural information is critical for developing GGT1 inhibitors. γ-Glutamyl transpeptidase 1 (GGT1) is a cell surface, N-terminal nucleophile hydrolase that cleaves glutathione and other γ-glutamyl compounds. GGT1 expression is essential in cysteine homeostasis, and its induction has been implicated in the pathology of asthma, reperfusion injury, and cancer. In this study, we report four new crystal structures of human GGT1 (hGGT1) that show conformational changes within the active site as the enzyme progresses from the free enzyme to inhibitor-bound tetrahedral transition states and finally to the glutamate-bound structure prior to the release of this final product of the reaction. The structure of the apoenzyme shows flexibility within the active site. The serine-borate-bound hGGT1 crystal structure demonstrates that serine-borate occupies the active site of the enzyme, resulting in an enzyme-inhibitor complex that replicates the enzyme's tetrahedral intermediate/transition state. The structure of GGsTop-bound hGGT1 reveals its interactions with the enzyme and why neutral phosphonate diesters are more potent inhibitors than monoanionic phosphonates. These structures are the first structures for any eukaryotic GGT that include a molecule in the active site covalently bound to the catalytic Thr-381. The glutamate-bound structure shows the conformation of the enzyme prior to release of the final product and reveals novel information regarding the displacement of the main chain atoms that form the oxyanion hole and movement of the lid loop region when the active site is occupied. These data provide new insights into the mechanism of hGGT1-catalyzed reactions and will be invaluable in the development of new classes of hGGT1 inhibitors for therapeutic use. Background: γ-Glutamyl transpeptidase 1 (GGT1) plays a role in asthma, reperfusion injury, and cancer. Results: We report four new crystal structures of human GGT1, including the free enzyme, inhibitor-bound transition states, and glutamate-bound enzyme. Conclusion: Novel enzyme-substrate interactions and movement of the catalytic nucleophile, oxyanion hole, and lid loop were revealed. Significance: This structural information is critical for developing GGT1 inhibitors." @default.
• W1951830410 created "2016-06-24" @default.
• W1951830410 creator A5015543492 @default.
• W1951830410 creator A5018188998 @default.
• W1951830410 creator A5022115475 @default.
• W1951830410 creator A5042020819 @default.
• W1951830410 creator A5055253170 @default.
• W1951830410 creator A5078658868 @default.
• W1951830410 date "2015-07-01" @default.
• W1951830410 modified "2023-10-16" @default.
• W1951830410 title "Human γ-Glutamyl Transpeptidase 1" @default.
• W1951830410 cites W143722950 @default.
• W1951830410 cites W1539796472 @default.
• W1951830410 cites W1633567371 @default.
• W1951830410 cites W1969574928 @default.
• W1951830410 cites W1979840983 @default.
• W1951830410 cites W1982558653 @default.
• W1951830410 cites W1985811656 @default.
• W1951830410 cites W1989344941 @default.
• W1951830410 cites W1990193113 @default.
• W1951830410 cites W2002195659 @default.
• W1951830410 cites W2008405285 @default.
• W1951830410 cites W2008699255 @default.
• W1951830410 cites W2027697602 @default.
• W1951830410 cites W2033893724 @default.
• W1951830410 cites W2038840577 @default.
• W1951830410 cites W2042792520 @default.
• W1951830410 cites W2053715143 @default.
• W1951830410 cites W2059480981 @default.
• W1951830410 cites W2067337056 @default.
• W1951830410 cites W2081912151 @default.
• W1951830410 cites W2082465243 @default.
• W1951830410 cites W2095210131 @default.
• W1951830410 cites W2098650139 @default.
• W1951830410 cites W2108921801 @default.
• W1951830410 cites W2123802253 @default.
• W1951830410 cites W2132629607 @default.
• W1951830410 cites W2135774343 @default.
• W1951830410 cites W2141360643 @default.
• W1951830410 cites W2144081223 @default.
• W1951830410 cites W2146122808 @default.
• W1951830410 cites W2160737442 @default.
• W1951830410 cites W2401693717 @default.
• W1951830410 cites W2412495336 @default.
• W1951830410 doi "https://doi.org/10.1074/jbc.m115.659680" @default.
• W1951830410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4498091" @default.
• W1951830410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26013825" @default.
• W1951830410 hasPublicationYear "2015" @default.
• W1951830410 type Work @default.
• W1951830410 sameAs 1951830410 @default.
• W1951830410 citedByCount "49" @default.
• W1951830410 countsByYear W19518304102015 @default.
• W1951830410 countsByYear W19518304102016 @default.
• W1951830410 countsByYear W19518304102017 @default.
• W1951830410 countsByYear W19518304102018 @default.
• W1951830410 countsByYear W19518304102019 @default.
• W1951830410 countsByYear W19518304102020 @default.
• W1951830410 countsByYear W19518304102021 @default.
• W1951830410 countsByYear W19518304102022 @default.
• W1951830410 countsByYear W19518304102023 @default.
• W1951830410 crossrefType "journal-article" @default.
• W1951830410 hasAuthorship W1951830410A5015543492 @default.
• W1951830410 hasAuthorship W1951830410A5018188998 @default.
• W1951830410 hasAuthorship W1951830410A5022115475 @default.
• W1951830410 hasAuthorship W1951830410A5042020819 @default.
• W1951830410 hasAuthorship W1951830410A5055253170 @default.
• W1951830410 hasAuthorship W1951830410A5078658868 @default.
• W1951830410 hasBestOaLocation W19518304101 @default.
• W1951830410 hasConcept C107824862 @default.
• W1951830410 hasConcept C13053905 @default.
• W1951830410 hasConcept C161790260 @default.
• W1951830410 hasConcept C178907741 @default.
• W1951830410 hasConcept C179506582 @default.
• W1951830410 hasConcept C181199279 @default.
• W1951830410 hasConcept C185592680 @default.
• W1951830410 hasConcept C192604958 @default.
• W1951830410 hasConcept C2776414213 @default.
• W1951830410 hasConcept C2780120296 @default.
• W1951830410 hasConcept C2780900081 @default.
• W1951830410 hasConcept C41183919 @default.
• W1951830410 hasConcept C47701112 @default.
• W1951830410 hasConcept C55493867 @default.
• W1951830410 hasConcept C71240020 @default.
• W1951830410 hasConceptScore W1951830410C107824862 @default.
• W1951830410 hasConceptScore W1951830410C13053905 @default.
• W1951830410 hasConceptScore W1951830410C161790260 @default.
• W1951830410 hasConceptScore W1951830410C178907741 @default.
• W1951830410 hasConceptScore W1951830410C179506582 @default.
• W1951830410 hasConceptScore W1951830410C181199279 @default.
• W1951830410 hasConceptScore W1951830410C185592680 @default.
• W1951830410 hasConceptScore W1951830410C192604958 @default.
• W1951830410 hasConceptScore W1951830410C2776414213 @default.
• W1951830410 hasConceptScore W1951830410C2780120296 @default.
• W1951830410 hasConceptScore W1951830410C2780900081 @default.
• W1951830410 hasConceptScore W1951830410C41183919 @default.
• W1951830410 hasConceptScore W1951830410C47701112 @default.
• W1951830410 hasConceptScore W1951830410C55493867 @default.
• W1951830410 hasConceptScore W1951830410C71240020 @default.

• next